BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14960659)

  • 21. Synthesis and characterization of nitroimidazole derivatives for 68Ga-labeling and testing in tumor xenografted mice.
    Hoigebazar L; Jeong JM; Choi SY; Choi JY; Shetty D; Lee YS; Lee DS; Chung JK; Lee MC; Chung YK
    J Med Chem; 2010 Sep; 53(17):6378-85. PubMed ID: 20690646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gallium-68 labeled red cells and platelets: new agents for positron tomography.
    Welch MJ; Thakur ML; Coleman RE; Patel M; Siegel BA; Ter-Pogossian M
    J Nucl Med; 1977 Jun; 18(6):558-62. PubMed ID: 404404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Ga derivatives of the H2dedpa scaffold with improved clearance and persistent heart uptake.
    Boros E; Ferreira CL; Patrick BO; Adam MJ; Orvig C
    Nucl Med Biol; 2011 Nov; 38(8):1165-74. PubMed ID: 21831655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antisense oligonucleotides.
    Herdewijn P
    Verh K Acad Geneeskd Belg; 1996; 58(4):359-81. PubMed ID: 8956554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodistribution of 68Ga-labeled LNA-DNA mixmer antisense oligonucleotides for rat chromogranin-A.
    Lendvai G; Velikyan I; Estrada S; Eriksson B; Långström B; Bergström M
    Oligonucleotides; 2008; 18(1):33-49. PubMed ID: 18321161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New 68Ga-labeled skeletal-imaging agents for positron scintigraphy.
    Dewanjee MK; Hnatowich DJ; Beh R
    J Nucl Med; 1976 Nov; 17(11):1003-7. PubMed ID: 978248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy using antisense oligodeoxynucleotides labeled with Auger-emitting radionuclides.
    Kairemo KJ; Tenhunen M; Jekunen AP
    Cancer Gene Ther; 1998; 5(6):408-12. PubMed ID: 9917096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative evaluation of the improvement in the pharmacokinetics of a nucleic acid drug delivery system by dynamic PET imaging with (18)F-incorporated oligodeoxynucleotides.
    Mukai H; Ozaki D; Cui Y; Kuboyama T; Yamato-Nagata H; Onoe K; Takahashi M; Wada Y; Imanishi T; Kodama T; Obika S; Suzuki M; Doi H; Watanabe Y
    J Control Release; 2014 Apr; 180():92-9. PubMed ID: 24566256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Divalent cobalt as a label to study lymphocyte distribution using PET and SPECT.
    Korf J; Veenma-van der Duin L; Brinkman-Medema R; Niemarkt A; de Leij LF
    J Nucl Med; 1998 May; 39(5):836-41. PubMed ID: 9591586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid-supported NOTA and DOTA chelators useful for the synthesis of 3'-radiometalated oligonucleotides.
    Kiviniemi A; Mäkelä J; Mäkilä J; Saanijoki T; Liljenbäck H; Poijärvi-Virta P; Lönnberg H; Laitala-Leinonen T; Roivainen A; Virta P
    Bioconjug Chem; 2012 Sep; 23(9):1981-8. PubMed ID: 22871148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, 68Ga labeling and preliminary evaluation of DOTA peptide binding vascular adhesion protein-1: a potential PET imaging agent for diagnosing osteomyelitis.
    Ujula T; Salomäki S; Virsu P; Lankinen P; Mäkinen TJ; Autio A; Yegutkin GG; Knuuti J; Jalkanen S; Roivainen A
    Nucl Med Biol; 2009 Aug; 36(6):631-41. PubMed ID: 19647169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gallium-68-DOTA-albumin as a PET blood-pool marker: experimental evaluation in vivo.
    Hoffend J; Mier W; Schuhmacher J; Schmidt K; Dimitrakopoulou-Strauss A; Strauss LG; Eisenhut M; Kinscherf R; Haberkorn U
    Nucl Med Biol; 2005 Apr; 32(3):287-92. PubMed ID: 15820764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 68Ga-labeled gold glyconanoparticles for exploring blood-brain barrier permeability: preparation, biodistribution studies, and improved brain uptake via neuropeptide conjugation.
    Frigell J; García I; Gómez-Vallejo V; Llop J; Penadés S
    J Am Chem Soc; 2014 Jan; 136(1):449-57. PubMed ID: 24320878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-hybridization saturable mechanisms play a role in the uptake of (68)Ga-Labeled LNA-DNA mixmer antisense oligonucleotides in rats.
    Lendvai G; Monazzam A; Velikyan I; Eriksson B; Josephsson R; Långström B; Bergström M; Estrada S
    Oligonucleotides; 2009 Sep; 19(3):223-32. PubMed ID: 19732020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triaza-based amphiphilic chelators: synthetic route, in vitro characterization and in vivo studies of their Ga(III) and Al(III) chelates.
    de Sá A; Prata MI; Geraldes CF; André JP
    J Inorg Biochem; 2010 Oct; 104(10):1051-62. PubMed ID: 20656358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gallium-68 labeling of albumin and albumin microspheres.
    Wagner SJ; Welch MJ
    J Nucl Med; 1979 May; 20(5):428-33. PubMed ID: 120419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiolabelling and preliminary evaluation of 68Ga-tetrapyrrole derivatives as potential tracers for PET.
    Zoller F; Riss PJ; Montforts FP; Kelleher DK; Eppard E; Rösch F
    Nucl Med Biol; 2013 Feb; 40(2):280-8. PubMed ID: 23265666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Labelling of commercially available human serum albumin kits with 68Ga as surrogates for 99mTc-MAA microspheres.
    Maus S; Buchholz HG; Ament S; Brochhausen C; Bausbacher N; Schreckenberger M
    Appl Radiat Isot; 2011 Jan; 69(1):171-5. PubMed ID: 20880714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-circulating non-toxic blood pool imaging agent based on hyperbranched polyglycerols.
    Saatchi K; Gelder N; Gershkovich P; Sivak O; Wasan KM; Kainthan RK; Brooks DE; Häfeli UO
    Int J Pharm; 2012 Jan; 422(1-2):418-27. PubMed ID: 22044540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary evaluation of novel 68Ga-DOTAVAP-PEG-P2 peptide targeting vascular adhesion protein-1.
    Silvola J; Autio A; Luoto P; Jalkanen S; Roivainen A
    Clin Physiol Funct Imaging; 2010 Jan; 30(1):75-8. PubMed ID: 19840033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.